Education

A, 1991, Biochemical Sciences, Harvard College, Cambridge, MA
MD, 1995, Medicine, Johns Hopkins School of Medicine, Baltimore, MD
General surgery & urology, UCSF, 1995-2001
Laparoscopic fellowship, UCSF, 2001-2002
Oncology fellowship, UCSF, 2002-2003

Honors & Awards

  • 1987
    Westinghouse Science Talent Search, 7th Place
  • 1991
    Magna cum laude, Harvard College
  • 1995
    Alpha Omega Alpha, Johns Hopkins
  • 1999
    Third Prize, Northern California Urology Residents Seminar
  • 1999
    Pfizer Scholar in Urology
  • 2001
    Joseph F. McCarthy Essay Contest, 3rd Place, Western Section AUA
  • 2002
    Prostate Cancer Research Fellow
  • 2004
    William R. Smart Distinguished Teaching Award (selected by residents)
  • 2005
    Excellence in Direct Teaching, Academy of Medical Educators, UCSF
  • 2006
    Ambrose/Reed Socioeconomic Prize Essay (AUA)
  • 2006
    AUA leadership Program (1 of 16 selected nationally biennially)
  • 2006
    Miley B. Wesson Essay Contest, 2nd Place, AUA

Selected Publications

  1. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP Liposomal bupivacaine decreases post-operative length of stay and opioid use in patients undergoing radical cystectomy.  View on PubMed
  2. Washington SL, Gregorich SE, Meng MV, Suskind AM, Porten SP Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.  View on PubMed
  3. de la Calle CM, Washington SL, Lonergan PE, Meng MV, Porten SP Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database.  View on PubMed
  4. Zuniga KB, Washington SL, Porten SP, Meng MV Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer Database.  View on PubMed
  5. Oh DY, Kwek SS, Raju SS, Li T, McCarthy E, Chow E, Aran D, Ilano A, Pai CS, Rancan C, Allaire K, Burra A, Sun Y, Spitzer MH, Mangul S, Porten S, Meng MV, Friedlander TW, Ye CJ, Fong L Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.  View on PubMed
  6. Zuniga KB, Washington SL, Porten SP, Meng MV A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database.  View on PubMed
  7. Chu CE, Porten SP, Grossfeld GD, Meng MV Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer.  View on PubMed
  8. Synold TW, Plets M, Tangen CM, Heath EI, Palapattu GS, Mack PC, Stein MN, Meng MV, Lara P, Vogelzang NJ, Thompson IM, Ryan CW Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249).  View on PubMed
  9. Washington SL, Neuhaus J, Meng MV, Porten SP Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.  View on PubMed
  10. Herlemann A, Meng MV Editorial: Conversion to negative surgical margin after intraoperative frozen section - (un)necessary effort and relevance in 2019?  View on PubMed
  11. Meng MV, Gschwend JE, Shore N, Grossfeld GD, Mostafid H, Black PC Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer.  View on PubMed
  12. Balakrishnan AS, Washington SL, Meng MV, Porten SP Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.  View on PubMed
  13. Hampson LA, Odisho AY, Meng MV Variation in Laparoscopic Nephrectomy Surgical Costs: Opportunities for High Value Care Delivery.  View on PubMed
  14. Schmidt B, Meng MV, Hampson LA Operating Room Supply Cost Awareness: A Cross-Sectional Analysis.  View on PubMed
  15. Hussein AA, Sexton KJ, May PR, Meng MV, Hosseini A, Eun DD, Daneshmand S, Bochner BH, Peabody JO, Abaza R, Skinner EC, Hautmann RE, Guru KA Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men.  View on PubMed
  16. Sanford T, Meng MV, Railkar R, Agarwal PK, Porten SP Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.  View on PubMed
  17. Wallace E, Higuchi R, Satya M, McCann L, Sin MLY, Bridge JA, Wei H, Zhang J, Wong E, Hiar A, Mach KE, Scherr D, Egerdie RB, Ohta S, Sexton WJ, Meng MV, Weizer AZ, Woods M, Jansz GK, Zadra J, Lotan Y, Goldfarb B, Liao JC Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection.  View on PubMed
  18. Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.  View on PubMed
  19. Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy.  View on PubMed
  20. Meng M Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6371S-6376S.  View on PubMed

Go to UCSF Profiles, powered by CTSI